COMMUNICATIONS
Min-Tsang Hsieh et al.
[4] E. Lee, M. K. Choi, H. J. Youk, C. H. Kim, I. C. Han,
B. C. Yoo, M. K. Lee, S. J. Lim, J. Cancer Res. Clin.
Oncol. 2006, 132, 223–233.
[5] G. P. Lahm, T. P. Selby, J. H. Freudenberger, T. M. Ste-
venson, B. J. Myers, G. Seburyamo, B. K. Smith, L.
Flexner, C. E. Clark, D. Cordova, Bioorg. Med. Chem.
Lett. 2005, 15, 4898–4906.
[6] M. L. Quan, P. Y. S. Lam, Q. Han, D. J. P. Pinto, M. Y.
He, R. Li, C. D. Ellis, C. G. Clark, C. A. Teleha, J.-H.
Sun, R. S. Alexander, S. Bai, J. M. Luettgen, R. M.
Knabb, P. C. Wong, R. R. Wexler, J. Med. Chem. 2005,
48, 1729–1744.
Experimental Section
General Procedure for the Synthesis of 3-Trifluoro-
methylpyrazoles
The general procedure is described below, with compound
6a used as a specific example. To a stirred solution of com-
pounds 4a (0.200 g, 1.00 mmol) and 5a (0.109 g, 1.00 mmol)
in CH2Cl2 (3 mL), Cu(OAc)2 (3.6 mg, 0.02 mmol) was
added. The resulting mixture was stirred under reflux for
1 h. Then, a saturated NH4Cl solution (1 mL) was added to
quench the reaction. The aqueous layer was separated and
extracted with CH2Cl2 (2ꢁ3 mL). The combined organic ex-
tracts were washed with brine, dried over MgSO4, filtered
and concentrated to yield the crude residue, which was puri-
fied by flash chromatography on silica gel with EtOAc/n-
hexane (1:9) to afford compound 6a; yield: 0.280 g (96%).
[7] B. D. Maxwell, J. Labelled. Cpd. Radiopharm. 2000, 43,
645–654.
[8] a) K. Makino, H. S. Kim, Y. Kurasawa, J. Heterocycl.
Chem. 1998, 35, 489–497; b) Z. Wang, H. Qin, Green
Chem. 2004, 6, 90–92; c) Y. L. Janin, Chem. Rev. 2012,
112, 3924–3958; d) S. Fustero, M. Sꢃnchez-Rosellꢄ, P.
Barrio, A. Simꢄn-Fuentes, Chem. Rev. 2011, 111, 6984–
7034, and references cited therein.
General Procedure for the Synthesis of 5-Trifluoro-
methylpyrazoles
[9] For recent examples, see: a) J. P. Waldo, S. Mehta,
R. C. Larock, J. Org. Chem. 2008, 73, 6666–6670;
b) F. A. Rosa, P. Machado, P. S. Vargas, H. G. Bonacor-
so, N. Zanatta, M. A. P. Martins, Synlett 2008, 11, 1673–
1678; c) C. P. Frizzo, M. R. B. Marzari, L. Buriol, D. N.
Moreira, F. A. Rosa, P. S. Vargas, N. Zanatta, H. G. Bo-
nacorso, M. A. P. Martins, Catal. Commun. 2009, 10,
1967–1970; d) W. Jin, H. Yu, Z. Yu, Tetrahedron Lett.
2011, 52, 5884–5887; e) M. Zora, A. Kivrak, C. Yazici,
J. Org. Chem. 2011, 76, 6726–6742; f) J. D. Kirkham,
S. J. Edeson, S. Stokes, J. P. A. Harrity, Org. Lett. 2012,
14, 5354–5357; g) D. X. Xiang, X. H. Bi, P. Q. Liao,
G. C. Fang, Z. K. Wang, X. Q. Xin, D. W. Dong, RSC
Adv. 2013, 3, 386–389.
The general procedure is described below, with compound
7a used as a specific example. A mixture of compounds 4a
(0.200 g, 1.00 mmol) and 5a (0.109 g, 1.00 mmol) in DMSO
(3 mL) was stirred at room temperature (208C) for 1 h. The
resulting mixture was heated to 1108C and stirred for an ad-
ditional 14 h. Water (6 mL) was added to quench the reac-
tion. The aqueous layer was separated and extracted with
EA (3ꢁ3 mL). The combined organic extracts were washed
with brine, dried over MgSO4, filtered and concentrated to
yield the crude residue, which was purified by flash chroma-
tography on silica gel with EtOAc/n-hexane (1:9) to afford
compound 7a; yield: 0.262 g (90%).
[10] The lack of regioselectivity has been reported by sever-
al authors. For reviews, see refs.[8c,8d]
Acknowledgements
[11] a) P. S. Humphries, J. M. Finefield, Tetrahedron Lett.
2006, 47, 2443–2446; b) L. Buriol, C. P. Frizzo, L. D. T.
Prola, D. N. Moreira, M. R. B. Marzari, E. Scapin, N.
Zanatta, H. G. Bonacorso, M. A. P. Martins, Catal. Lett.
2011, 141, 1130–1135.
[12] a) M. A. P. Martins, M. R. B. Marzari, C. P. Frizzo, M.
Zanatta, L. Buriol, V. P. Andrade, N. Zanatta, H. G.
Bonacorso, Eur. J. Org. Chem. 2012, 36, 7112–7119;
b) S. Fustero, R. Romꢃn, J. F. Sanz-Cervera, A. Simꢄn-
Fuentes, A. C. CuÇat, S. Villanova, M. Murguꢅa, J. Org.
Chem. 2008, 73, 3523–3529.
We are grateful to the Taiwan Ministry of Science and Tech-
nology (MOST 103-2113M-039-002-MY2) and Chinese Med-
icine Research Center, China Medical University (the Minis-
try of Education, the Aim for the Top University Plan) for fi-
nancial support.
References
[13] F. Li, J. Nie, L. Sun, Y. Zheng, J.-A. Ma, Angew. Chem.
[1] a) A. Schmidt, A. Dreger, Curr. Org. Chem. 2011, 15,
1423–1463; b) J. Elguero, A. M. S. Silva, A. C. Tomꢂ,
in: Modern Heterocyclic Chemistry, 1st edn., (Eds.: J.
Alvarez-Builla, J. J. Vaquero, J. Barluenga, Wiley-VCH,
Weinheim, 2011, pp 635–725.
[2] T. D. Penning, J. J. Talley, S. R. Bertenshaw, J. S. Carter,
P. W. Collins, S. Docter, M. J. Graneto, L. F. Lee, J. W.
Malecha, J. M. Miyashiro, R. S. Rogers, D. J. Rogier,
S. S. Yu, G. D. Anderson, E. G. Burton, J. N. Cogburn,
S. A. Gregory, C. M. Koboldt, W. E. Perkins, K. Seibert,
A. W. Veenhuizen, Y. Y. Zhang, P. C. Isakson, J. Med.
Chem. 1997, 40, 1347–1365.
Int. Ed. 2013, 52, 6255–6258.
[14] R. S. Foster, H. Jakobi, J. P. A. Harrity, Org. Lett. 2012,
14, 4858–4861.
[15] G. Ji, X. Wang, S. Zhang, Y. Xu, Y. Ye, M. Li, Y.
Zhang, J. Wang, Chem. Commun. 2014, 50, 4361–4363.
[16] R. Reddy, V. Ramma, S. C. Bell, WO Patent WO
2003024958A3, 2003.
[17] a) N. P. Grimster, C. Gauntlett, C. R. A. Godfrey, M. J.
Gaunt, Angew. Chem. 2005, 117, 3185–3189; b) L. Hin-
termann, R. Masuo, K. Suzuki, Org. Lett. 2008, 10,
4859–4862; c) A. W. Garner, C. F. Harris, D. A. K.
Vezzu, R. D. Pike, S. Huo, Chem. Commun. 2011, 47,
1902–1904; d) C.-D. Wang, Y.-F. Hsieh, R.-S. Liu, Adv.
Synth. Catal. 2014, 356, 144–152.
[3] A. Sun, J. J. Yoon, Y. Yin, A. Prussia, Y. Yang, J. Min,
R. K. Plemper, J. P. Snyder, J. Med. Chem. 2008, 51,
3731–3741.
6
ꢀ 2015 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
Adv. Synth. Catal. 0000, 000, 0 – 0
ÝÝ
These are not the final page numbers!